WO1992019721A1 - Expression genique dans des bacilles - Google Patents
Expression genique dans des bacilles Download PDFInfo
- Publication number
- WO1992019721A1 WO1992019721A1 PCT/US1992/003403 US9203403W WO9219721A1 WO 1992019721 A1 WO1992019721 A1 WO 1992019721A1 US 9203403 W US9203403 W US 9203403W WO 9219721 A1 WO9219721 A1 WO 9219721A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- enzyme
- bacillus
- promoter
- gene
- regulatory genes
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 title claims description 18
- 244000052616 bacterial pathogen Species 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 claims abstract description 81
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 69
- 102000004190 Enzymes Human genes 0.000 claims abstract description 64
- 238000000034 method Methods 0.000 claims abstract description 18
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 50
- 108090000787 Subtilisin Proteins 0.000 claims description 39
- 230000035772 mutation Effects 0.000 claims description 38
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 29
- 101100498939 Bacillus subtilis (strain 168) degS gene Proteins 0.000 claims description 28
- 108700005075 Regulator Genes Proteins 0.000 claims description 25
- 101150085919 degQ gene Proteins 0.000 claims description 24
- 101150057070 HPR gene Proteins 0.000 claims description 23
- 238000004519 manufacturing process Methods 0.000 claims description 21
- 101100339392 Escherichia coli (strain K12) hlyE gene Proteins 0.000 claims description 20
- 101150045242 ptsH gene Proteins 0.000 claims description 20
- 230000002103 transcriptional effect Effects 0.000 claims description 20
- 101150009206 aprE gene Proteins 0.000 claims description 11
- 101150086155 abrB gene Proteins 0.000 claims description 9
- 101100298851 Aspergillus oryzae (strain ATCC 42149 / RIB 40) prtT gene Proteins 0.000 claims description 8
- 101100298845 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) prtR gene Proteins 0.000 claims description 8
- 101150023726 degR gene Proteins 0.000 claims description 8
- 101150112117 nprE gene Proteins 0.000 claims description 8
- 108700028369 Alleles Proteins 0.000 claims description 7
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 6
- 108090001060 Lipase Proteins 0.000 claims description 5
- 102000004882 Lipase Human genes 0.000 claims description 5
- 239000004367 Lipase Substances 0.000 claims description 5
- 235000019421 lipase Nutrition 0.000 claims description 5
- 101000895926 Streptomyces plicatus Endo-beta-N-acetylglucosaminidase H Proteins 0.000 claims description 4
- 230000001276 controlling effect Effects 0.000 claims description 4
- -1 sin Proteins 0.000 claims 4
- 239000013598 vector Substances 0.000 abstract description 13
- 241000304886 Bacilli Species 0.000 abstract description 11
- 229940088598 enzyme Drugs 0.000 description 38
- 239000013612 plasmid Substances 0.000 description 28
- 101100017691 Bacillus subtilis (strain 168) hpr gene Proteins 0.000 description 14
- 238000013518 transcription Methods 0.000 description 13
- 230000035897 transcription Effects 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 12
- 108091005658 Basic proteases Proteins 0.000 description 11
- 238000010276 construction Methods 0.000 description 10
- 239000012634 fragment Substances 0.000 description 10
- 102000035195 Peptidases Human genes 0.000 description 9
- 108091005804 Peptidases Proteins 0.000 description 9
- 239000004365 Protease Substances 0.000 description 9
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 8
- 210000000349 chromosome Anatomy 0.000 description 8
- 101150113191 cmr gene Proteins 0.000 description 8
- 239000006166 lysate Substances 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 238000010361 transduction Methods 0.000 description 7
- 230000026683 transduction Effects 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 5
- 229960005091 chloramphenicol Drugs 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 101100028789 Arabidopsis thaliana PBS1 gene Proteins 0.000 description 4
- 108010022999 Serine Proteases Proteins 0.000 description 4
- 102000012479 Serine Proteases Human genes 0.000 description 4
- 108010056079 Subtilisins Proteins 0.000 description 4
- 102000005158 Subtilisins Human genes 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000003362 replicative effect Effects 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 108090000145 Bacillolysin Proteins 0.000 description 3
- 108090000317 Chymotrypsin Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108091005507 Neutral proteases Proteins 0.000 description 3
- 102000035092 Neutral proteases Human genes 0.000 description 3
- 101150046895 SCOC gene Proteins 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 229960002376 chymotrypsin Drugs 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 210000003495 flagella Anatomy 0.000 description 3
- 101150050908 hisA gene Proteins 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 206010061765 Chromosomal mutation Diseases 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 101100202529 Danio rerio scoca gene Proteins 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 241000286904 Leptothecata Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 101150077403 priA gene Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003355 serines Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- INMYHLJNCIBJSD-KOKHDOHPSA-N (2s)-2-aminobutanedioic acid;(2s)-2-amino-3-hydroxypropanoic acid;(2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid Chemical compound OC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CC1=CNC=N1 INMYHLJNCIBJSD-KOKHDOHPSA-N 0.000 description 1
- 101150007523 32 gene Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 241000702198 Bacillus virus PBS1 Species 0.000 description 1
- 108700038091 Beta-glucanases Proteins 0.000 description 1
- 241001416152 Bos frontalis Species 0.000 description 1
- 101100328086 Caenorhabditis elegans cla-1 gene Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 239000007478 blood agar base Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 101150066351 catA gene Proteins 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 108010005400 cutinase Proteins 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 125000000404 glutamine group Chemical class N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 150000002742 methionines Chemical class 0.000 description 1
- 108010020132 microbial serine proteinases Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 101150065453 prtR gene Proteins 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- 101150033202 thr gene Proteins 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- JLYXXMFPNIAWKQ-UHFFFAOYSA-N γ Benzene hexachloride Chemical compound ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl JLYXXMFPNIAWKQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
Definitions
- the invention relates to novel genes, vectors and Bacilli transformed with them useful in the hyperproduction of enzymes. Specifically, the invention relates to specific combinations of unlinked genes which, either mutated or wild type, synergistically induce hyperproduction of enzymes.
- Bacillus subtilis 1-168 is the most extensively studied member of the Bacilli and has a well developed genetic system as the result of many years of academic research. As a result, there is a considerable amount of knowledge pertaining to the expression of extracellular enzymes and many mutants of B. subtilis 1-168 exist that are altered in the expression of these enzymes. There are several different known genes which code for proteins that regulate the expression of extracellular enzymes. Although the exact molecular mechanism of this regulation is not completely
- Regions of the ENA around promoters can actively interact with certain transcriptional control factors and effectively regulate the strength and efficiency of a particular promoter. This interaction will result either in a stimulation or in a repression of the transcription of that particular target gene. As a consequence, mutations in either the genes coding for these transcriptional control factors or in regions of the chromosome with which they interact are expected to yield more or less mRNA of the target gene. This in turn will results in higher or lower amount of enzyme synthesized by the cell.
- sacU genes which have the most pleiotropic effect among all these known regulatory genes.
- a strain carrying for example sacU(Hy) mutations can sporulate in presence of high levels of glucose, has a very low efficiency of transformation, lacks flagella and it is also responsible for the hyperprcducticn of several secreted enzymes. (Dedonder et al, Microbiology 1976, see above).
- the sacQ gene from three different bacilli has been cloned and
- the gene isolated from B. subtilis encodes a 46 amino acid polypeptide.
- the sacQ gene when hyperexpressed either because of a mutation in its promoter or when present in a multicopy plasmid causes hyper production of certain extracellular enzymes, including the alkaline protease (Yang et al, 1986, J. Bacteriol 166, 113-119).
- the prtR gene encodes a 60 amino acid polypeptide. When this gene is present in B. subtilis in a multicopy plasmid it causes increased
- the hpr gene encodes a 203 amino acid protein and certain mutations in this gene stimulate alkaline protease production. It has been established that mutations which cause the loss of this gene product stimulates transcription of the subtilisin gene (Perego and Hoch, 1988, J. Bacteriol. 170, 2560-2567). The product of the hpr gene therefore is most likely a repressor of the subtilisin gene. It has also been determined that the scoC gene and possibly the catA gene are identical to the hpr. The notation hpr will be used thereafter to refer to any of the three alleles called hpr, scoC or catA.
- the sin gene encodes a polypeptide of 111 amino acids (Gaur et al, 1986, J. Bacteriol, 168:860-869).
- An insertional ina ⁇ tivation of the gene causes the production of a higher level of alkaline protease, suggesting that this gene also acts as a repressor of the expression of alkaline protease.
- abrB gene codes for a polypeptide of 97 amino acids. Also for this gene there is evidence that it is a repressor of the transcription of the alkaline protease and might have an important role in the temporal regulation of this gene.
- the invention relates to a Bacillus able to hyperprcduce an enzyme comprising:
- mutated genes are preferably selected from the group comprising:
- the invention also relates to vectors comprising the novel gene, to cells-transformed with the vectors and to a processing for making enzymes.
- Figure 1 shows the construction of the pSAR gene.
- Figure 2 shows the construction of the pSAICM gene.
- Figure 3 shows the integration of the pSAICM gene into the B. subtilis chromosome.
- Applicants have demonstrated novel cxambination of mutated or wild type genes, vectors and Bacilli transformed with them which are unique in their ability to induce hyperproduction of enzymes.
- Two mutated genes as described above are introduced in a strain carrying an appropriate promoter and gene sequence.
- the promoter sequence and the gene sequence of the enzyme are introduced into such host strain by mean of an integrative vector.
- Such vector which may or may not be amplified upon integration, is stably maintained as part of the host genome and replicates within the cell as integral part of its chromosome, integration can occur at different region of the chromosome including but not limited to the region of homology with the promoter used in a particular construction.
- Such host may have its original enzyme sequences, or other gene sequences,
- enzyme gene sequence refers to a ENA sequence encoding for the expression of an enzyme, in general either heterologous or homologous to Bacilli.
- enzymes are known and within the scope of this teaching including but not limited to those preferred enzymes from
- Bacillus lentus Bacillus amyloliquefaciens (e.g., ATCC 23844), Bacillus licheniformis (e.g., ATCC 21415), Bacillus alcal ⁇ philus (e.g., ATCC 21522), B. subtilis (e.g., ATCC 6051) and Bacillus cereus (e.g., ATCC 21768). Also included are all the genes capable of being expressed in Bacillus such as the ones coding for proteases, lipases, cutinases, esterases,
- subtilisin A preferred enzyme is subtilisin.
- Other preferred enzymes include endoglycosidase H from Streptomyces species and lipase from Pseud ⁇ monas mendocino ATCC 53552 (available from American Type Culture Collection, Rockville, MD). Enzymes such as subtilisin which act at an optimum at higher pH are among the preferred enzymes. It is also desirable to act at an optimum at higher pH. It is also
- the enzyme gene sequence also includes the DNA sequence encoding for a naturally occurring enzyme gene sequence vSiich is modified to produce a mutant ENA sequence which encodes a substitution, insertion or deletion of one or more amino acids in the gene sequence. Suitable modification methods are disclosed in, for example, EPO Publication No. 0130756, published January 9, 1985.
- Subtilisins are bacterial alkaline proteases which generally act to cleave peptide bonds of proteins or peptides.
- subtilisin means a naturally occurring subtilisin or a reccmbinant subtilisin.
- a series of naturally occurring subtilisins is known to be produced and often secreted by various bacterial species. Amino acid sequences of the members of this series are not entirely homologous. However, the subtilisins in this series exhibit the same or similar type of proteolytic activity.
- This class of serine proteases shares a common amino acid sequence defining a catalytic triad which distinguishes them from the chymotrypsin related class of serine proteases.
- subtilisins and chymotrypsin related serine proteases both have a catalytic triad comprising aspartate, histidine and serine.
- subtilisin related proteases the relative order of these animo acids, reading from the amino to carboxyl terminus is
- subtilisin herein refers to a serine protease.
- Recombinant subtilisin refers to a subtilisin in which the DNA sequence encoding the subtilisin is modified to produce a mutant ENA sequence which encodes the substitution, deletion or insertion of one or more amino acids in the naturally occurring subtilisin amino acid sequence. Suitable methods to produce such modification include those disclosed herein and in EPO Publication No. 0130756.
- a subtilisin multiple mutant containing the substitution of methionine at amino acid residues 50, 124 and 222 with phenylalanine, isoleucine and glutamine, respectively can be considered to be derived from the rec ⁇ mbinant subtilisin containing the substitution of glutamine at residue 222 (Gln-222) disclosed in EPO
- the multiple mutant thus is produced by the substitution of phenylalanine for methionine at residue 50 and isoleucine for methionine at residue 124 in the Gln-222 re ⁇ ombinant subtilisin.
- a functional promoter sequence controlling the expression of the enzyme gene operably linked to the enzyme gene sequence refers to a promoter sequence which, controls the transcription and translation of the coding sequence in Bacillus.
- the promoter sequence is chosen so that it is functional in the microorganism, chosen for expression.
- promoter sequence including ribosomal binding sites formed from Lambda P (Renaut, et al., Gene 15, 81 [1981]) as well as the trp (Russell, et al., Gene 20, 23 (1982)or tac (de Boer et al., PNAS. USA 80, 21 [1983]) may be cperably linked to coding sequences to express alkaline protease in E.
- B. subtilis 1-168 is the expression host, the B ⁇ . subtilis alkaline protease promoter (Stahl et al, J. Bacteriol 158, 411-418 [1984]) alpha amylase promoter of B. subtilis (Yang et al., 1983, Nucleic Acids Res. 11, 237-249) or B. amyloliquefaciens (Tarkinen, et al, J. Biol. Chem. 258, 1007-1013 [1983]), the neutral protease promoter from B. subtilis
- transcriptional regulatory genes refers to any of the genes whose product affects the level of transcription from the enzyme promoter. These genes product can interact at the promoter level (e.g. AbrB) or with a region upstream or downstream of it (e.g. Hpr, SacU, SacQ, PrtR, Sin) either directly or indirectly.
- the definition above is comprehensive of the gene product or the lacik of it and any possible mutation which may increase the level of transcription of a particular promoter (e.g. multiple copies). This definition is meant to include but not limited to certain mutations in the promoter region, downstream or upstream of the promoter region of the target gene which may result in an increase in transcription due to a better interaction or lack of it with the regulatory genes or with the transcriptional machinery (e.g. RNA polymerase, mutations which decrease production of a gene product which interferes with transcription). These genes and the effect of their mutations are described above. These specific combinations, applicant has discovered, exhibit a synergistic effect when compared with the results predicted from either single mutations alone.
- “Expression vector” refers to a ENA construct containing a ENA sequence which is operably linked to a suitable control sequence capable of effecting the expression of the ENA in a suitable host.
- control sequences can include a promoter to effect transcription or optional operation sequence to control such transcription, a sequence encoding a suitable ribosome binding sites (RBS) and sequences which control
- the vector may be a plasmid, a phage particle, or a potential genomic insert. Once transformed into a suitable host, the vector may replicate and function independently of the host gene or may integrate into the gene itself.
- a preferred vector is pSAI.
- Bacillus host cells for the purpose of this invention are those
- Bacillus hosts capable of functionally accepting the expression vector Preferably, they have been manipulated by the methods disclosed in EPO Publication No. 0130756 to render them incapable of secreting other enzymes deleterious to the desired enzyme.
- a preferred host cell for expressing subtilisin is the B. subtilis strain BG 2036 which is deficient in
- subtilisin enzymatically active neutral protease and alkaline protease
- the construction of strain BG 2036 is described in detail in EPO Publication No. 0130756 and further described by Yang, et al (1984) J. Bacteriol. 16015-21.
- Other host cells for expressing subtilisin include any derivative of B. subtilis 1-168 and any other member of the bacillus family in which such system might work (i.e. B. amyloliquefaciens and B. licheniformis (EPO Publication No. 0130756).
- operably linked describes the relationship between two ENA regions and means they are functionally related to one another.
- a promoter is operably linked to the gene sequence coding for an alkaline protease if it properly controls the transcription of the sequence.
- subtilisin gene from B. amyloliquefaciens was isolated as described by Wells et al, 1983, Nucleic Acid Res. 11: 7911-7925. Briefly, partially Sau3A digested chromosomal ENA from B. amyloliquefaciens was ligated to BamHl digested pBS42 and used to transform E. coli.
- pBS42 is a plasmid vector composed of an origin of replication from pUB110 recognized as such by B. subtilis, an origin of replication from pBR322 which allows
- acetyltransferase from pC194, a fully characterized plasmid from Staphilococcus aureus (Horinouchi and Wei ⁇ blum, 1982), which can express CmR in both E. coli and B. subtilis.
- Synthetic ENA probes designed from the known amino acid sequence of the subtilisin were used to isolate a plasmid (p54) carrying the ENA coding for the gene.
- the isolated ENA fragment was able to code for subtilisin production when transferred to B. subtilis and the ENA sequence translated to match the published amino acid sequence of the alkaline protease (Wells et al, 1983, Nucleic Acid Res. 11: 7911-7925) .
- a Sau3A BamH1 fragment from pS4-5 (a derivative of pS4) comprising the subtilisin structural gene from the 8th codon of the signal sequence to 250 bp after the 3' end of the gene (all of which is B. amyloliquefaciens ENA), was fused to a 750 bp EcoR1-Sau3A fragment which carries the promoter and the first 8 codons of the translated sequence of the B. subtilis subtilisin gene (Fig. 1).
- B. subtilis consists of 1.6 Kb from pC194 and the subtilisin gene joined together by short linker regions.
- One linker is composed of 20 bp from pUC9, and the other one consists of the 17 bp from pBR322 included between the EcoR1 and the Cla1 sites.
- chromosomal mutations known to increase the level of secreted enzymes either through competent cell transformation or PBS1 transduction. Both these techniques are commonly used for genetic studies in B. subtilis.
- the resulting strain is a prototrophic sporeforming derivative of B. subtilis 1-168 (catalog No. 1- A1, Bacillus Genetic Stock Center) which carries the B. amyloliquefaciens subtilisin gene and the CmR gene from pC194 integrated into the chromosome.
- chloramphenicol resistance The resulting chloramphenicol resistant strains were scored on solid medium (tryptose blood agar base agar, TBAB) containing skim milk for the detection of the hyperprotease producing characteristic (due to the presence of the scoC, catA and hpr mutations) of the parent strain.
- PBS-1 lysates (see above) were prepared on the ScoC, CatA and Hpr strains carrying the pSAI integrative plasmid by a standard published technique (Hcch et al 1967, see above). These lysates were used to transduce strain BG2097.
- transductant Same of the transductant were screened en plates containing 1.6% skim milk and compared to BG3002. Transductants able to yield a larger halo on these type of plates were selected and strains BG 3008, BG3005 and BG3007 were obtained.
- the genotype of these strains is isogeneic (hisA, aprE, nprE, pSAI::CmR) except for the hpr gene were the mutations scoCl, catA or hpr?7 are present respectively.
- representatives of this transduction were examined in shake flasks using a nutrient broth medium, they produced -19-17mg/L subtilisin or 5-10 fold more than the strain that did not contain the hyperproducing mutation.
- SacU(Hy) strains One of the properties of SacU(Hy) strains is that they lack the ability to produce flagella and to became motile. Since PBS-1 attaches to motile flagella, it is impossible to prepare a PBS-1 working lysate on SacU(By) strains. This problem was circumvented by the isolation of a spontaneous mutant that was motile and retained its protease hyperproducing phenotype. The nature of the mutation that results in motility is unknown. A lysate was prepared on the motile SacU(Hy) strain.
- This lysate was used to transduce either BG3002 ( ⁇ apr, ⁇ npr, hisA) containing the pSAI plasmid to histidine prototropy. Since the sacU gene and the hisA gene are linked by transduction, a certain
- strains containing both the sacU(Hy)32 and either the scoC or catA mutations exhibited a larger zone of clearing on skim milk plates than did either of the strains containing the individual mutations. These strains produced ⁇ 55mg/L in nutrient broth medium.
- SacQ(By) strains A lysate was prepared on a SacQ(Hy) strain. This lysate was used to transduce a strain to threonine
- sacQ(Hy) and either the scoC or catA mutation could be constructed by using a combination of the above procedures.
- the catA/scoC mutation was introduced in one step along with the plasmid pSAI, followed by the introduction of the saoQ(Hy) mutation and finally the sacU(Hy) mutation was introduced into the strain.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019930703241A KR100230613B1 (ko) | 1991-04-26 | 1992-04-24 | 간균내 유전자 발현 |
CA002108358A CA2108358C (fr) | 1991-04-26 | 1992-04-24 | Expression de genes dans des bacilles |
FI934717A FI934717A0 (fi) | 1991-04-26 | 1992-04-24 | Genexpression i bacillus |
DE69230825T DE69230825T2 (de) | 1991-04-26 | 1992-04-24 | Genexpression in bazillen |
EP92911495A EP0600893B1 (fr) | 1991-04-26 | 1992-04-24 | Expression genique dans des bacilles |
AU19111/92A AU663321B2 (en) | 1991-04-26 | 1992-04-24 | Gene expression in bacilli |
JP4511425A JP2654472B2 (ja) | 1991-04-26 | 1992-04-24 | バシラス属中の遺伝子発現 |
DK92911495T DK0600893T3 (da) | 1991-04-26 | 1992-04-24 | Genekspression i Bacilli |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69210891A | 1991-04-26 | 1991-04-26 | |
US692,108 | 1991-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992019721A1 true WO1992019721A1 (fr) | 1992-11-12 |
Family
ID=24779295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/003403 WO1992019721A1 (fr) | 1991-04-26 | 1992-04-24 | Expression genique dans des bacilles |
Country Status (11)
Country | Link |
---|---|
US (1) | US5387521A (fr) |
EP (1) | EP0600893B1 (fr) |
JP (1) | JP2654472B2 (fr) |
KR (1) | KR100230613B1 (fr) |
AU (1) | AU663321B2 (fr) |
CA (1) | CA2108358C (fr) |
DE (1) | DE69230825T2 (fr) |
DK (1) | DK0600893T3 (fr) |
FI (1) | FI934717A0 (fr) |
NZ (1) | NZ242507A (fr) |
WO (1) | WO1992019721A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993020214A1 (fr) * | 1992-03-30 | 1993-10-14 | Genencor International, Inc. | Expression genique heterologue dans le bacillum subtilis: approche par fusion |
WO2003083125A1 (fr) * | 2002-03-29 | 2003-10-09 | Genencor International, Inc. | Expression proteinique amelioree dans bacillus |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646044A (en) * | 1995-03-02 | 1997-07-08 | Henkel Kommanditgesellschaft Auf Aktien | Expression systems for the production of target proteins in bacillus |
GB9828711D0 (en) * | 1998-12-24 | 1999-02-17 | Genencor Int | Production of proteins in gram-positive microorganisms |
EP1472347B1 (fr) * | 2002-02-15 | 2011-01-12 | Danisco US Inc. | Accroissement de l expression de proteines dans le bacillus subtilis |
US20050026189A1 (en) * | 2003-05-29 | 2005-02-03 | Liangsu Wang | Microbial operons |
US20090048136A1 (en) * | 2007-08-15 | 2009-02-19 | Mcdonald Hugh C | Kappa-carrageenase and kappa-carrageenase-containing compositions |
AR076941A1 (es) | 2009-06-11 | 2011-07-20 | Danisco Us Inc | Cepa de bacillus para una mayor produccion de proteina |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4801541A (en) * | 1981-09-11 | 1989-01-31 | The University Of Rochester | Method of increasing the yield of a product by altering a microorganism |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2582316B1 (fr) * | 1985-05-22 | 1988-12-02 | Centre Nat Rech Scient | Vecteurs d'expression de l'a-amylase dans bacillus subtilis, souches obtenues et procede de preparation d'a-amylase |
-
1992
- 1992-04-24 AU AU19111/92A patent/AU663321B2/en not_active Ceased
- 1992-04-24 DE DE69230825T patent/DE69230825T2/de not_active Expired - Lifetime
- 1992-04-24 KR KR1019930703241A patent/KR100230613B1/ko not_active Expired - Fee Related
- 1992-04-24 FI FI934717A patent/FI934717A0/fi not_active Application Discontinuation
- 1992-04-24 EP EP92911495A patent/EP0600893B1/fr not_active Expired - Lifetime
- 1992-04-24 WO PCT/US1992/003403 patent/WO1992019721A1/fr active IP Right Grant
- 1992-04-24 JP JP4511425A patent/JP2654472B2/ja not_active Expired - Lifetime
- 1992-04-24 CA CA002108358A patent/CA2108358C/fr not_active Expired - Lifetime
- 1992-04-24 DK DK92911495T patent/DK0600893T3/da active
- 1992-04-27 NZ NZ242507A patent/NZ242507A/en not_active IP Right Cessation
-
1993
- 1993-06-02 US US08/071,210 patent/US5387521A/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4801541A (en) * | 1981-09-11 | 1989-01-31 | The University Of Rochester | Method of increasing the yield of a product by altering a microorganism |
Non-Patent Citations (4)
Title |
---|
Applied and Environmental Microbiology, Volume 39, No. 1, issued January 1980, YONEDA et al., "Increased Production of Extracellular Enzymes by the Synergistic Effect of Genes Introduced into Bacillus subtilis by Stepwise Transformation", pages 274-276, see entire document. * |
Gene, Volume 83, issued 1989, WONG, "Development of an inducible and enhanciboe expression and secretion system in Bacillus subtilis", pages 215-223. * |
Journal of Bacteriology, Volume 170, No. 1, issued January 1988, HENNER et al., "Location of the Targets of the hpr-97, sacO32(Hy), and sacU36(Hy) Mutations in Upstream Regions of the Subtilisin Promoter", pages 296-300, see entire document, especially the introduction. * |
See also references of EP0600893A4 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993020214A1 (fr) * | 1992-03-30 | 1993-10-14 | Genencor International, Inc. | Expression genique heterologue dans le bacillum subtilis: approche par fusion |
WO2003083125A1 (fr) * | 2002-03-29 | 2003-10-09 | Genencor International, Inc. | Expression proteinique amelioree dans bacillus |
US8124399B2 (en) | 2002-03-29 | 2012-02-28 | Danisco Us Inc. | Enhanced protein expression in Bacillus |
US8383366B2 (en) | 2002-03-29 | 2013-02-26 | Danisco Us Inc. | Enhanced protein expression in Bacillus |
US9175294B2 (en) | 2002-03-29 | 2015-11-03 | Danisco Us Inc. | Enhanced protein expression in Bacillus |
Also Published As
Publication number | Publication date |
---|---|
JPH06507075A (ja) | 1994-08-11 |
JP2654472B2 (ja) | 1997-09-17 |
DE69230825T2 (de) | 2000-11-30 |
NZ242507A (en) | 1994-04-27 |
DE69230825D1 (de) | 2000-04-27 |
US5387521A (en) | 1995-02-07 |
EP0600893B1 (fr) | 2000-03-22 |
AU1911192A (en) | 1992-12-21 |
CA2108358A1 (fr) | 1992-10-27 |
FI934717L (fi) | 1993-10-25 |
KR100230613B1 (ko) | 1999-12-01 |
AU663321B2 (en) | 1995-10-05 |
EP0600893A4 (fr) | 1994-11-30 |
CA2108358C (fr) | 2002-11-19 |
EP0600893A1 (fr) | 1994-06-15 |
DK0600893T3 (da) | 2000-08-21 |
FI934717A0 (fi) | 1993-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0284126B1 (fr) | Amplification de gènes stable dans l'ADN chromosomique des prokaryotes | |
US5217878A (en) | Molecular cloning and expression of genes encoding proteolytic enzymes | |
EP0283075B1 (fr) | Clonage moléculaire et expression de gènes codant pour des enzymes protéolytiques | |
JP4870306B2 (ja) | 変異体apreプロモーター | |
JP2590247B2 (ja) | スブチリシンアナログ | |
US6783970B2 (en) | System for expressing hyperthermostable protein | |
US5843720A (en) | Introduction of DNA into bacillus strains by conjugation | |
EP0600893B1 (fr) | Expression genique dans des bacilles | |
US5716807A (en) | Transformed industrial bacillus strains and methods for making and using them | |
JP3490435B2 (ja) | 突然変異プロテアーゼの効率的生産 | |
US5238833A (en) | Molecular cloning and expression in industrial Bacillus species | |
Honjo et al. | Cloning and expression of the gene for neutral protease of Bacillus amyloliquefaciens in Bacillus subtilis | |
WANG et al. | Construction of a Bacillus subtilis mutant-deficient in three extracellular proteases | |
JPH01141596A (ja) | アルカリプロテアーゼをコードする遺伝子系 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA FI JP KR |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2108358 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 934717 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992911495 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1992911495 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1992911495 Country of ref document: EP |